Gene therapy for Lafora disease in the Epm2a-/- mouse model.
Zafra-Puerta L, Iglesias-Cabeza N, Burgos DF, Sciaccaluga M, González-Fernández J, Bellingacci L, Canonichesi J, Sánchez-Martín G, Costa C, Sánchez MP, Serratosa JM.
Zafra-Puerta L, et al. Among authors: gonzalez fernandez j.
Mol Ther. 2024 May 24:S1525-0016(24)00334-4. doi: 10.1016/j.ymthe.2024.05.032. Online ahead of print.
Mol Ther. 2024.
PMID: 38796707